RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer

Abstract Ovarian cancer is a disease with increasing incidence worldwide, and there is an urgent need for chemotherapy and biological targeted therapy. Epithelial-mesenchymal transformation (EMT) is an important initiation stage for tumor cells to acquire the ability to invade and metastasize. A gro...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiao Ping Xu, Kui Deng, Zhen Zhang, Hongkai Shang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-023-01103-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846121776422060032
author Qiao Ping Xu
Kui Deng
Zhen Zhang
Hongkai Shang
author_facet Qiao Ping Xu
Kui Deng
Zhen Zhang
Hongkai Shang
author_sort Qiao Ping Xu
collection DOAJ
description Abstract Ovarian cancer is a disease with increasing incidence worldwide, and there is an urgent need for chemotherapy and biological targeted therapy. Epithelial-mesenchymal transformation (EMT) is an important initiation stage for tumor cells to acquire the ability to invade and metastasize. A growing number of findings suggest that human Schlafen family member 5(SLFN5) plays a key role in malignancy. However, the role of SLFN5 in ovarian cancer cells has not been fully elucidated. Samples were collected from patients with ovarian cancer diagnosed in Hangzhou First People's Hospital, and the expression of SLFN5 was detected by fluorescence quantitative PCR. The relationship between SLFN5 expression and the progression and malignancy of ovarian cancer was analyzed by using the expression profile data from the Cancer Genome Atlas (TCGA) database. The mRNA expression levels of SLFN5 related upstream and downstream signaling pathways were studied by fluorescence quantitative PCR. Silencing SLFN5 was performed by siRNA transfection. The expression of SLFN5 and transfer-related proteins was examined by Western blot. Transwell and wound healing experiments investigated the migration and invasion ability of ovarian cancer cells. TCGA database analysis results showed that in the population with high SLFN5 expression, compared with the group with low SLFN5 expression, OS was worse (P = 0.011). SLFN5 silencing had a significant inhibitory effect on EMT and invasion movement of ovarian cancer cells. RT-PCR method was used to detect the mRNA changes of SLFN5 in ovarian cancer tissue and adjacent tissue. It was found that the expression of SLFN5 in ovarian cancer tissue was increased, with a significant difference (P < 0.05). Together, these results suggest that SLFN5 may play a synergistic role in tumorigenesis and development of ovarian cancer cells, providing a potential target for future drug development for the treatment of ovarian cancer.
format Article
id doaj-art-2fd6ec4dd7c347fa8add4056433b8340
institution Kabale University
issn 1757-2215
language English
publishDate 2023-02-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj-art-2fd6ec4dd7c347fa8add4056433b83402024-12-15T12:11:39ZengBMCJournal of Ovarian Research1757-22152023-02-0116111410.1186/s13048-023-01103-7RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancerQiao Ping Xu0Kui Deng1Zhen Zhang2Hongkai Shang3Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou, First People’s HospitalWestlake Institute for Advanced StudyDepartment of Oncology, Hangzhou Cancer HospitalDepartment of Gynecology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineAbstract Ovarian cancer is a disease with increasing incidence worldwide, and there is an urgent need for chemotherapy and biological targeted therapy. Epithelial-mesenchymal transformation (EMT) is an important initiation stage for tumor cells to acquire the ability to invade and metastasize. A growing number of findings suggest that human Schlafen family member 5(SLFN5) plays a key role in malignancy. However, the role of SLFN5 in ovarian cancer cells has not been fully elucidated. Samples were collected from patients with ovarian cancer diagnosed in Hangzhou First People's Hospital, and the expression of SLFN5 was detected by fluorescence quantitative PCR. The relationship between SLFN5 expression and the progression and malignancy of ovarian cancer was analyzed by using the expression profile data from the Cancer Genome Atlas (TCGA) database. The mRNA expression levels of SLFN5 related upstream and downstream signaling pathways were studied by fluorescence quantitative PCR. Silencing SLFN5 was performed by siRNA transfection. The expression of SLFN5 and transfer-related proteins was examined by Western blot. Transwell and wound healing experiments investigated the migration and invasion ability of ovarian cancer cells. TCGA database analysis results showed that in the population with high SLFN5 expression, compared with the group with low SLFN5 expression, OS was worse (P = 0.011). SLFN5 silencing had a significant inhibitory effect on EMT and invasion movement of ovarian cancer cells. RT-PCR method was used to detect the mRNA changes of SLFN5 in ovarian cancer tissue and adjacent tissue. It was found that the expression of SLFN5 in ovarian cancer tissue was increased, with a significant difference (P < 0.05). Together, these results suggest that SLFN5 may play a synergistic role in tumorigenesis and development of ovarian cancer cells, providing a potential target for future drug development for the treatment of ovarian cancer.https://doi.org/10.1186/s13048-023-01103-7Ovarian cancerSLFN5Epithelial-mesenchymal transitionInvasion
spellingShingle Qiao Ping Xu
Kui Deng
Zhen Zhang
Hongkai Shang
RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
Journal of Ovarian Research
Ovarian cancer
SLFN5
Epithelial-mesenchymal transition
Invasion
title RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
title_full RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
title_fullStr RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
title_full_unstemmed RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
title_short RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
title_sort retracted article slfn5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
topic Ovarian cancer
SLFN5
Epithelial-mesenchymal transition
Invasion
url https://doi.org/10.1186/s13048-023-01103-7
work_keys_str_mv AT qiaopingxu retractedarticleslfn5promotesreversibleepithelialandmesenchymaltransformationinovariancancer
AT kuideng retractedarticleslfn5promotesreversibleepithelialandmesenchymaltransformationinovariancancer
AT zhenzhang retractedarticleslfn5promotesreversibleepithelialandmesenchymaltransformationinovariancancer
AT hongkaishang retractedarticleslfn5promotesreversibleepithelialandmesenchymaltransformationinovariancancer